sep-4199
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Jun 26, 2018 (NCT03543410)
Timeline
Indications
Studied for
Mechanism of action
- Serotonin 7 (5-HT7) receptorACTIVATOR
HTR7 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sep-4199
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05227209 | Phase 3 | Mar 17, 2022 | Sunovion |
| NCT05169710 | Phase 3 | Dec 21, 2021 | Sumitomo Dainippon |
| NCT03543410 | Phase 2 | Jun 26, 2018 | Sunovion |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sunovion | For profit | 2 | 2 | 2 | 2018 |
| Sumitomo Dainippon | For profit | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1